Error in Figure Labels

PMC · DOI:10.1001/jamanetworkopen.2026.5720·March 20, 2026

Error in Figure Labels

PDF

Open Access

Abstract

Linked entities

Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.

Diseases1

Prostate Cancer

Peer Reviews

No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.

Videos

No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.

Taxonomy

TopicsReliability and Agreement in Measurement · Clinical Reasoning and Diagnostic Skills · Meta-analysis and systematic reviews

Full text

In the Original Investigation titled “SBRT vs HDR Brachytherapy for Intermediate-Risk Prostate Cancer,”^1^ published February 25, 2026, “adverse events” in panel titles and y-axis labels in Figure 2 was mislabeled as “toxic effects.” The article has been corrected.^1^

Bibliography1

The reference list from the paper itself. Each links out to its DOI / PubMed record.

1Udovicich C, Cheung P, Chu W, . SBRT vs HDR brachytherapy for intermediate-risk prostate cancer. JAMA Netw Open. 2026;9(2):e 260146. doi:10.1001/jamanetworkopen.2026.014641739470 PMC 12936880 · doi ↗ · pubmed ↗